Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy.

J Immunother Cancer · 2022 · PMC8968986 · PMID 35354588

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In patients with AKI, longer duration of AKI was associated with higher mortality (HR 1.84 (95% CI 1.30 to 2.62)) and severe AKI (stage 2 or higher) showed a trend towards higher mortality (HR 1.32 (95% CI 0.98 to 1.79), ( online supplemental table S4 )).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.